link
Bookmarks
 (0)
Obstetrics
Diagnosis
Musculoskeletal
Dysplasias
Atelosteogenesis
Atelosteogenesis
Janice L. B. Byrne, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
1
0
1

KEY FACTS

  • Imaging

    • Top Differential Diagnoses

      • Clinical Issues

        TERMINOLOGY

        • Definitions

          • Rhizomelic short limb skeletal dysplasia

        IMAGING

        • Ultrasonographic Findings

          • Radiographic Findings

            • Imaging Recommendations

              DIFFERENTIAL DIAGNOSIS

                PATHOLOGY

                • General Features

                  CLINICAL ISSUES

                  • Natural History & Prognosis

                    Selected References

                    1. Jeon GW et al: Identification of a de novo heterozygous missense FLNB mutation in lethal atelosteogenesis type I by exome sequencing. Ann Lab Med. 34(2):134-8, 2014
                    2. Wessels A et al: Atelosteogenesis type I: autopsy findings. Pediatr Dev Pathol. 14(6):496-500, 2011
                    3. Dwyer E et al: Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family. Am J Med Genet A. 152A(12):3043-50, 2010
                    4. Luewan S et al: Prenatal sonographic features of fetal atelosteogenesis type 1. J Ultrasound Med. 28(8):1091-5, 2009
                    5. Sawyer GM et al: Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains. J Mol Biol. 390(5):1030-47, 2009
                    6. Cordier AG et al: Prenatal diagnosis of a rare skeletal dysplasia by ultrasound and scan tomography: atelosteogenesis III (AO III). Correlation with autopsy. Prenat Diagn. 28(10):975-7, 2008
                    7. Miller E et al: Fetal MR imaging of atelosteogenesis type II (AO-II). Pediatr Radiol. 38(12):1345-9, 2008
                    8. Miyake A et al: A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia. J Hum Genet. 53(8):764-8, 2008
                    9. Lu J et al: Filamin B mutations cause chondrocyte defects in skeletal development. Hum Mol Genet. 16(14):1661-75, 2007
                    10. Zhou X et al: Filamin B deficiency in mice results in skeletal malformations and impaired microvascular development. Proc Natl Acad Sci U S A. 104(10):3919-24, 2007
                    11. Farrington-Rock C et al: Mutations in two regions of FLNB result in atelosteogenesis I and III. Hum Mutat. 27(7):705-10, 2006
                    12. Forlino A et al: Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. Novartis Found Symp. 273:193-206; discussion 206-12, 261-4, 2006
                    13. Maeda K et al: A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia. Am J Med Genet A. 140(11):1143-7, 2006
                    14. Bicknell LS et al: Mutations in FLNB cause boomerang dysplasia. J Med Genet. 42(7):e43, 2005
                    15. Fernandez-Aguilar S et al: Diagnosis of atelosteogenesis type II after a routine echography at 12 weeks' pregnancy. Prenat Diagn. 25(8):717-8, 2005
                    16. Forlino A et al: A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum Mol Genet. 14(6):859-71, 2005
                    17. Krakow D et al: Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet. 36(4):405-10, 2004
                    18. Macías-Gómez NM et al: Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: first report of a Mexican patient and genotype-phenotype correlation. Am J Med Genet A. 129A(2):190-2, 2004
                    19. Ueno K et al: Prenatal diagnosis of atelosteogenesis type I at 21 weeks' gestation. Prenat Diagn. 22(12):1071-5, 2002
                    20. Karniski LP: Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype. Hum Mol Genet. 10(14):1485-90, 2001
                    Related Anatomy
                    Loading...
                    Related Differential Diagnoses
                    Loading...
                    References
                    Tables

                    Tables

                    KEY FACTS

                    • Imaging

                      • Top Differential Diagnoses

                        • Clinical Issues

                          TERMINOLOGY

                          • Definitions

                            • Rhizomelic short limb skeletal dysplasia

                          IMAGING

                          • Ultrasonographic Findings

                            • Radiographic Findings

                              • Imaging Recommendations

                                DIFFERENTIAL DIAGNOSIS

                                  PATHOLOGY

                                  • General Features

                                    CLINICAL ISSUES

                                    • Natural History & Prognosis

                                      Selected References

                                      1. Jeon GW et al: Identification of a de novo heterozygous missense FLNB mutation in lethal atelosteogenesis type I by exome sequencing. Ann Lab Med. 34(2):134-8, 2014
                                      2. Wessels A et al: Atelosteogenesis type I: autopsy findings. Pediatr Dev Pathol. 14(6):496-500, 2011
                                      3. Dwyer E et al: Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family. Am J Med Genet A. 152A(12):3043-50, 2010
                                      4. Luewan S et al: Prenatal sonographic features of fetal atelosteogenesis type 1. J Ultrasound Med. 28(8):1091-5, 2009
                                      5. Sawyer GM et al: Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains. J Mol Biol. 390(5):1030-47, 2009
                                      6. Cordier AG et al: Prenatal diagnosis of a rare skeletal dysplasia by ultrasound and scan tomography: atelosteogenesis III (AO III). Correlation with autopsy. Prenat Diagn. 28(10):975-7, 2008
                                      7. Miller E et al: Fetal MR imaging of atelosteogenesis type II (AO-II). Pediatr Radiol. 38(12):1345-9, 2008
                                      8. Miyake A et al: A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia. J Hum Genet. 53(8):764-8, 2008
                                      9. Lu J et al: Filamin B mutations cause chondrocyte defects in skeletal development. Hum Mol Genet. 16(14):1661-75, 2007
                                      10. Zhou X et al: Filamin B deficiency in mice results in skeletal malformations and impaired microvascular development. Proc Natl Acad Sci U S A. 104(10):3919-24, 2007
                                      11. Farrington-Rock C et al: Mutations in two regions of FLNB result in atelosteogenesis I and III. Hum Mutat. 27(7):705-10, 2006
                                      12. Forlino A et al: Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. Novartis Found Symp. 273:193-206; discussion 206-12, 261-4, 2006
                                      13. Maeda K et al: A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia. Am J Med Genet A. 140(11):1143-7, 2006
                                      14. Bicknell LS et al: Mutations in FLNB cause boomerang dysplasia. J Med Genet. 42(7):e43, 2005
                                      15. Fernandez-Aguilar S et al: Diagnosis of atelosteogenesis type II after a routine echography at 12 weeks' pregnancy. Prenat Diagn. 25(8):717-8, 2005
                                      16. Forlino A et al: A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum Mol Genet. 14(6):859-71, 2005
                                      17. Krakow D et al: Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet. 36(4):405-10, 2004
                                      18. Macías-Gómez NM et al: Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: first report of a Mexican patient and genotype-phenotype correlation. Am J Med Genet A. 129A(2):190-2, 2004
                                      19. Ueno K et al: Prenatal diagnosis of atelosteogenesis type I at 21 weeks' gestation. Prenat Diagn. 22(12):1071-5, 2002
                                      20. Karniski LP: Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype. Hum Mol Genet. 10(14):1485-90, 2001